Starling Oncology, Inc. Finance Lease, Right-of-Use Asset, before Accumulated Amortization
Starling Oncology, Inc. (DFPH) had Finance Lease, Right-of-Use Asset, before Accumulated Amortization of $371.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Notes › Leases
us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization · last filed 2023-03-16
- 2022-12-31: Finance Lease, Right-of-Use Asset, before Accumulated Amortization $371.00K.
| Period end | Finance Lease, Right-of-Use Asset, before Accumulated Amortization |
|---|---|
| 2022-12-31 | $371.00K 10-K · filed 2023-03-16 |